1 Study Coverage 1.1 Human Vaccine Product Introduction 1.2 Market by Type 1.2.1 Global Human Vaccine Market Size Growth Rate by Type 1.2.2 Varicella 1.2.3 Influenza 1.2.4 Polio 1.2.5 Hepatitis A 1.2.6 Rabies 1.2.7 BCG 1.2.8 Hepatitis B 1.2.9 Pertussis, Diphtheria, Tetanus 1.2.10 Pneumococcal 1.2.11 Rota vaccine 1.3 Market by Application 1.3.1 Global Human Vaccine Market Size Growth Rate by Application 1.3.2 Adults 1.3.3 Children 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Vaccine Market Size, Estimates and Forecasts 2.1.1 Global Human Vaccine Revenue 2016-2027 2.1.2 Global Human Vaccine Sales 2016-2027 2.2 Global Human Vaccine, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Human Vaccine Historical Market Size by Region (2016-2021) 2.3.1 Global Human Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Human Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Human Vaccine Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Human Vaccine Sales Forecast by Region (2022-2027) 2.4.2 Global Human Vaccine Revenue Forecast by Region (2022-2027) 3 Global Human Vaccine Competitor Landscape by Players 3.1 Global Top Human Vaccine Manufacturers by Sales 3.1.1 Global Human Vaccine Sales by Manufacturer (2016-2021) 3.1.2 Global Human Vaccine Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Human Vaccine Manufacturers by Revenue 3.2.1 Key Human Vaccine Manufacturers Covered: Ranking by Revenue 3.2.2 Global Human Vaccine Revenue by Manufacturers (2016-2021) 3.2.3 Global Human Vaccine Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Human Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Human Vaccine Revenue in 2020 3.2.6 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Human Vaccine Price by Manufacturers 3.4 Global Human Vaccine Manufacturing Base Distribution, Product Types 3.4.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Human Vaccine Product Type 3.4.3 Date of International Manufacturers Enter into Human Vaccine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Human Vaccine Market Size by Type (2016-2021) 4.1.1 Global Human Vaccine Sales by Type (2016-2021) 4.1.2 Global Human Vaccine Revenue by Type (2016-2021) 4.1.3 Human Vaccine Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Human Vaccine Market Size Forecast by Type (2022-2027) 4.2.1 Global Human Vaccine Sales Forecast by Type (2022-2027) 4.2.2 Global Human Vaccine Revenue Forecast by Type (2022-2027) 4.2.3 Human Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Human Vaccine Market Size by Application (2016-2021) 5.1.1 Global Human Vaccine Sales by Application (2016-2021) 5.1.2 Global Human Vaccine Revenue by Application (2016-2021) 5.1.3 Human Vaccine Price by Application (2016-2021) 5.2 Human Vaccine Market Size Forecast by Application (2022-2027) 5.2.1 Global Human Vaccine Sales Forecast by Application (2022-2027) 5.2.2 Global Human Vaccine Revenue Forecast by Application (2022-2027) 5.2.3 Global Human Vaccine Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Human Vaccine Market Size YoY Growth 2016-2027 6.1.1 United States Human Vaccine Sales YoY Growth 2016-2027 6.1.2 United States Human Vaccine Revenue YoY Growth 2016-2027 6.1.3 United States Human Vaccine Market Share in Global Market 2016-2027 6.2 United States Human Vaccine Market Size by Players (International and Local Players) 6.2.1 United States Top Human Vaccine Players by Sales (2016-2021) 6.2.2 United States Top Human Vaccine Players by Revenue (2016-2021) 6.3 United States Human Vaccine Historic Market Review by Type (2016-2021) 6.3.1 United States Human Vaccine Sales Market Share by Type (2016-2021) 6.3.2 United States Human Vaccine Revenue Market Share by Type (2016-2021) 6.3.3 United States Human Vaccine Price by Type (2016-2021) 6.4 United States Human Vaccine Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Human Vaccine Sales Forecast by Type (2022-2027) 6.4.2 United States Human Vaccine Revenue Forecast by Type (2022-2027) 6.4.3 United States Human Vaccine Price Forecast by Type (2022-2027) 6.5 United States Human Vaccine Historic Market Review by Application (2016-2021) 6.5.1 United States Human Vaccine Sales Market Share by Application (2016-2021) 6.5.2 United States Human Vaccine Revenue Market Share by Application (2016-2021) 6.5.3 United States Human Vaccine Price by Application (2016-2021) 6.6 United States Human Vaccine Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Human Vaccine Sales Forecast by Application (2022-2027) 6.6.2 United States Human Vaccine Revenue Forecast by Application (2022-2027) 6.6.3 United States Human Vaccine Price Forecast by Application (2022-2027) 7 North America 7.1 North America Human Vaccine Market Size YoY Growth 2016-2027 7.2 North America Human Vaccine Market Facts & Figures by Country 7.2.1 North America Human Vaccine Sales by Country (2016-2021) 7.2.2 North America Human Vaccine Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Human Vaccine Market Size YoY Growth 2016-2027 8.2 Asia Pacific Human Vaccine Market Facts & Figures by Region 8.2.1 Asia Pacific Human Vaccine Sales by Region (2016-2021) 8.2.2 Asia Pacific Human Vaccine Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Human Vaccine Market Size YoY Growth 2016-2027 9.2 Europe Human Vaccine Market Facts & Figures by Country 9.2.1 Europe Human Vaccine Sales by Country (2016-2021) 9.2.2 Europe Human Vaccine Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Human Vaccine Market Size YoY Growth 2016-2027 10.2 Latin America Human Vaccine Market Facts & Figures by Country 10.2.1 Latin America Human Vaccine Sales by Country (2016-2021) 10.2.2 Latin America Human Vaccine Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Human Vaccine Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Human Vaccine Market Facts & Figures by Country 11.2.1 Middle East and Africa Human Vaccine Sales by Country (2016-2021) 11.2.2 Middle East and Africa Human Vaccine Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 CNBG 12.1.1 CNBG Corporation Information 12.1.2 CNBG Description and Business Overview 12.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.1.4 CNBG Human Vaccine Products Offered 12.1.5 CNBG Recent Development 12.2 Changsheng Life 12.2.1 Changsheng Life Corporation Information 12.2.2 Changsheng Life Description and Business Overview 12.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Changsheng Life Human Vaccine Products Offered 12.2.5 Changsheng Life Recent Development 12.3 Zhifei 12.3.1 Zhifei Corporation Information 12.3.2 Zhifei Description and Business Overview 12.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Zhifei Human Vaccine Products Offered 12.3.5 Zhifei Recent Development 12.4 ChengDa Bio 12.4.1 ChengDa Bio Corporation Information 12.4.2 ChengDa Bio Description and Business Overview 12.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.4.4 ChengDa Bio Human Vaccine Products Offered 12.4.5 ChengDa Bio Recent Development 12.5 Kangtai 12.5.1 Kangtai Corporation Information 12.5.2 Kangtai Description and Business Overview 12.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Kangtai Human Vaccine Products Offered 12.5.5 Kangtai Recent Development 12.6 SINOVAC BIOTECH 12.6.1 SINOVAC BIOTECH Corporation Information 12.6.2 SINOVAC BIOTECH Description and Business Overview 12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.6.4 SINOVAC BIOTECH Human Vaccine Products Offered 12.6.5 SINOVAC BIOTECH Recent Development 12.7 Hissen 12.7.1 Hissen Corporation Information 12.7.2 Hissen Description and Business Overview 12.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Hissen Human Vaccine Products Offered 12.7.5 Hissen Recent Development 12.8 Walvax Biotechnology 12.8.1 Walvax Biotechnology Corporation Information 12.8.2 Walvax Biotechnology Description and Business Overview 12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Walvax Biotechnology Human Vaccine Products Offered 12.8.5 Walvax Biotechnology Recent Development 12.9 GSK 12.9.1 GSK Corporation Information 12.9.2 GSK Description and Business Overview 12.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.9.4 GSK Human Vaccine Products Offered 12.9.5 GSK Recent Development 12.10 SANOFI 12.10.1 SANOFI Corporation Information 12.10.2 SANOFI Description and Business Overview 12.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.10.4 SANOFI Human Vaccine Products Offered 12.10.5 SANOFI Recent Development 12.11 CNBG 12.11.1 CNBG Corporation Information 12.11.2 CNBG Description and Business Overview 12.11.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.11.4 CNBG Human Vaccine Products Offered 12.11.5 CNBG Recent Development 12.12 NuoCheng Bio 12.12.1 NuoCheng Bio Corporation Information 12.12.2 NuoCheng Bio Description and Business Overview 12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.12.4 NuoCheng Bio Products Offered 12.12.5 NuoCheng Bio Recent Development 12.13 Hualan Bio 12.13.1 Hualan Bio Corporation Information 12.13.2 Hualan Bio Description and Business Overview 12.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Hualan Bio Products Offered 12.13.5 Hualan Bio Recent Development 12.14 Tiantan biological 12.14.1 Tiantan biological Corporation Information 12.14.2 Tiantan biological Description and Business Overview 12.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Tiantan biological Products Offered 12.14.5 Tiantan biological Recent Development 12.15 Changchun Baike 12.15.1 Changchun Baike Corporation Information 12.15.2 Changchun Baike Description and Business Overview 12.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Changchun Baike Products Offered 12.15.5 Changchun Baike Recent Development 12.16 Adimmune 12.16.1 Adimmune Corporation Information 12.16.2 Adimmune Description and Business Overview 12.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Adimmune Products Offered 12.16.5 Adimmune Recent Development 12.17 Zhongyianke Biotech 12.17.1 Zhongyianke Biotech Corporation Information 12.17.2 Zhongyianke Biotech Description and Business Overview 12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Zhongyianke Biotech Products Offered 12.17.5 Zhongyianke Biotech Recent Development 12.18 Bharat Biotech 12.18.1 Bharat Biotech Corporation Information 12.18.2 Bharat Biotech Description and Business Overview 12.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Bharat Biotech Products Offered 12.18.5 Bharat Biotech Recent Development 12.19 Bavarian Nordic 12.19.1 Bavarian Nordic Corporation Information 12.19.2 Bavarian Nordic Description and Business Overview 12.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Bavarian Nordic Products Offered 12.19.5 Bavarian Nordic Recent Development 12.20 Sanofi-Pasteur 12.20.1 Sanofi-Pasteur Corporation Information 12.20.2 Sanofi-Pasteur Description and Business Overview 12.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Sanofi-Pasteur Products Offered 12.20.5 Sanofi-Pasteur Recent Development 12.21 Indian Immunologicals 12.21.1 Indian Immunologicals Corporation Information 12.21.2 Indian Immunologicals Description and Business Overview 12.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Indian Immunologicals Products Offered 12.21.5 Indian Immunologicals Recent Development 12.22 KANGH 12.22.1 KANGH Corporation Information 12.22.2 KANGH Description and Business Overview 12.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.22.4 KANGH Products Offered 12.22.5 KANGH Recent Development 12.23 Henan Grand Biopharma 12.23.1 Henan Grand Biopharma Corporation Information 12.23.2 Henan Grand Biopharma Description and Business Overview 12.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Henan Grand Biopharma Products Offered 12.23.5 Henan Grand Biopharma Recent Development 12.24 ZhongKe Biopharm 12.24.1 ZhongKe Biopharm Corporation Information 12.24.2 ZhongKe Biopharm Description and Business Overview 12.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.24.4 ZhongKe Biopharm Products Offered 12.24.5 ZhongKe Biopharm Recent Development 12.25 Zhuoyi Biological 12.25.1 Zhuoyi Biological Corporation Information 12.25.2 Zhuoyi Biological Description and Business Overview 12.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Zhuoyi Biological Products Offered 12.25.5 Zhuoyi Biological Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Human Vaccine Industry Trends 13.2 Human Vaccine Market Drivers 13.3 Human Vaccine Market Challenges 13.4 Human Vaccine Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Human Vaccine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Human Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Varicella Table 3. Major Manufacturers of Influenza Table 4. Major Manufacturers of Polio Table 5. Major Manufacturers of Hepatitis A Table 6. Major Manufacturers of Rabies Table 7. Major Manufacturers of BCG Table 8. Major Manufacturers of Hepatitis B Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus Table 10. Major Manufacturers of Pneumococcal Table 11. Major Manufacturers of Rota vaccine Table 12. Global Human Vaccine Market Size Growth Rate by Application (2021-2027) & (M Doses) Table 13. Global Human Vaccine Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027 Table 14. Global Human Vaccine Sales by Regions (2016-2021) & (M Doses) Table 15. Global Human Vaccine Sales Market Share by Regions (2016-2021) Table 16. Global Human Vaccine Revenue by Regions (2016-2021) & (US$ Million) Table 17. Global Human Vaccine Sales Forecast by Region (2022-2027) & (M Doses) Table 18. Global Human Vaccine Sales Market Share Forecast by Region (2022-2027) Table 19. Global Human Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 20. Global Human Vaccine Revenue Market Share Forecast by Region (2022-2027) Table 21. Global Human Vaccine Sales by Manufacturers (2016-2021) (M Doses) Table 22. Global Human Vaccine Sales Share by Manufacturers (2016-2021) Table 23. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2020 Table 24. Human Vaccine Revenue by Manufacturers (2016-2021) (US$ Million) Table 25. Human Vaccine Revenue Share by Manufacturers (2016-2021) Table 26. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 27. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2020) Table 28. Key Manufacturers Human Vaccine Price (2016-2021) (USD/Dose) Table 29. Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table 30. Manufacturers Human Vaccine Product Type Table 31. Date of International Manufacturers Enter into Human Vaccine Market Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans Table 33. Global Human Vaccine Sales by Type (2016-2021) (M Doses) Table 34. Global Human Vaccine Sales Share by Type (2016-2021) Table 35. Global Human Vaccine Revenue by Type (2016-2021) (US$ Million) Table 36. Global Human Vaccine Revenue Share by Type (2016-2021) Table 37. Human Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose) Table 38. Global Human Vaccine Sales Forecast by Type (2022-2027) & (M Doses) Table 39. Global Human Vaccine Sales Market Share Forecast by Type (2022-2027) Table 40. Global Human Vaccine Revenue Forecast V (2022-2027) & (US$ Million) Table 41. Global Human Vaccine Revenue Market Share Forecast by Type (2022-2027) Table 42. Global Human Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose) Table 43. Global Human Vaccine Sales by Application (2016-2021) (M Doses) Table 44. Global Human Vaccine Sales Share by Application (2016-2021) Table 45. Global Human Vaccine Revenue by Application (2016-2021) (US$ Million) Table 46. Global Human Vaccine Revenue Share by Application (2016-2021) Table 47. Human Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose) Table 48. Global Human Vaccine Sales Forecast by Application (2022-2027) & (M Doses) Table 49. Global Human Vaccine Sales Market Share Forecast by Application (2022-2027) Table 50. Global Human Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 51. Global Human Vaccine Revenue Market Share Forecast by Application (2022-2027) Table 52. Global Human Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose) Table 53. United States Human Vaccine Sales (M Doses) of Key Companies (2016-2021) Table 54. United States Human Vaccine Sales Share by Company (2016-2021) Table 55. United States Human Vaccine Revenue (US$ Million) by Company (2016-2021) Table 56. United States Human Vaccine Revenue Share by Company (2016-2021) Table 57. United States Human Vaccine Sales (M Doses) by Type (2016-2021) Table 58. United States Human Vaccine Sales Share by Type (2016-2021) Table 59. United States Human Vaccine Revenue (US$ Million) Market Share by Type (2016-2021) Table 60. United States Human Vaccine Price (USD/Dose) by Type (2016-2021) Table 61. United States Human Vaccine Sales (M Doses) by Type (2022-2027) Table 62. United States Human Vaccine Sales Share by Type (2022-2027) Table 63. United States Human Vaccine Revenue (US$ Million) Market Share by Type (2022-2027) Table 64. United States Human Vaccine Revenue Share by Type (2022-2027) Table 65. United States Human Vaccine Price (USD/Dose) by Type (2022-2027) Table 66. United States Human Vaccine Sales (M Doses) by Application (2016-2021) Table 67. United States Human Vaccine Sales Share by Application (2016-2021) Table 68. United States Human Vaccine Revenue (US$ Million) Market Share by Application (2016-2021) Table 69. United States Human Vaccine Price (USD/Dose) by Application (2016-2021) Table 70. United States Human Vaccine Sales (M Doses) by Application (2022-2027) Table 71. United States Human Vaccine Sales Share by Application (2022-2027) Table 72. United States Human Vaccine Revenue (US$ Million) Market Share by Application (2022-2027) Table 73. United States Human Vaccine Revenue Share by Application (2022-2027) Table 74. United States Human Vaccine Price (USD/Dose) by Application (2022-2027) Table 75. North America Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 76. North America Human Vaccine Sales Market Share by Country (2016-2021) Table 77. North America Human Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 78. North America Human Vaccine Revenue Market Share by Country (2016-2021) Table 79. Asia Pacific Human Vaccine Sales by Region (2016-2021) & (M Doses) Table 80. Asia Pacific Human Vaccine Sales Market Share by Region (2016-2021) Table 81. Asia Pacific Human Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 82. Asia Pacific Human Vaccine Revenue Market Share by Region (2016-2021) Table 83. Europe Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 84. Europe Human Vaccine Sales Market Share by Country (2016-2021) Table 85. Europe Human Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 86. Europe Human Vaccine Revenue Market Share by Country (2016-2021) Table 87. Latin America Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 88. Latin America Human Vaccine Sales Market Share by Country (2016-2021) Table 89. Latin Americaa Human Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 90. Latin America Human Vaccine Revenue Market Share by Country (2016-2021) Table 91. Middle East and Africa Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 92. Middle East and Africa Human Vaccine Sales Market Share by Country (2016-2021) Table 93. Middle East and Africa Human Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 94. Middle East and Africa Human Vaccine Revenue Market Share by Country (2016-2021) Table 95. CNBG Corporation Information Table 96. CNBG Description and Business Overview Table 97. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 98. CNBG Human Vaccine Product Table 99. CNBG Recent Development Table 100. Changsheng Life Corporation Information Table 101. Changsheng Life Description and Business Overview Table 102. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 103. Changsheng Life Product Table 104. Changsheng Life Recent Development Table 105. Zhifei Corporation Information Table 106. Zhifei Description and Business Overview Table 107. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 108. Zhifei Product Table 109. Zhifei Recent Development Table 110. ChengDa Bio Corporation Information Table 111. ChengDa Bio Description and Business Overview Table 112. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 113. ChengDa Bio Product Table 114. ChengDa Bio Recent Development Table 115. Kangtai Corporation Information Table 116. Kangtai Description and Business Overview Table 117. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 118. Kangtai Product Table 119. Kangtai Recent Development Table 120. SINOVAC BIOTECH Corporation Information Table 121. SINOVAC BIOTECH Description and Business Overview Table 122. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 123. SINOVAC BIOTECH Product Table 124. SINOVAC BIOTECH Recent Development Table 125. Hissen Corporation Information Table 126. Hissen Description and Business Overview Table 127. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 128. Hissen Product Table 129. Hissen Recent Development Table 130. Walvax Biotechnology Corporation Information Table 131. Walvax Biotechnology Description and Business Overview Table 132. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 133. Walvax Biotechnology Product Table 134. Walvax Biotechnology Recent Development Table 135. GSK Corporation Information Table 136. GSK Description and Business Overview Table 137. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 138. GSK Product Table 139. GSK Recent Development Table 140. SANOFI Corporation Information Table 141. SANOFI Description and Business Overview Table 142. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 143. SANOFI Product Table 144. SANOFI Recent Development Table 145. Rong An Corporation Information Table 146. Rong An Description and Business Overview Table 147. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 148. Rong An Product Table 149. Rong An Recent Development Table 150. NuoCheng Bio Corporation Information Table 151. NuoCheng Bio Description and Business Overview Table 152. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 153. NuoCheng Bio Product Table 154. NuoCheng Bio Recent Development Table 155. Hualan Bio Corporation Information Table 156. Hualan Bio Description and Business Overview Table 157. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 158. Hualan Bio Product Table 159. Hualan Bio Recent Development Table 160. Tiantan biological Corporation Information Table 161. Tiantan biological Description and Business Overview Table 162. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 163. Tiantan biological Product Table 164. Tiantan biological Recent Development Table 165. Changchun Baike Corporation Information Table 166. Changchun Baike Description and Business Overview Table 167. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 168. Changchun Baike Product Table 169. Changchun Baike Recent Development Table 170. Adimmune Corporation Information Table 171. Adimmune Description and Business Overview Table 172. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 173. Adimmune Product Table 174. Adimmune Recent Development Table 175. Zhongyianke Biotech Corporation Information Table 176. Zhongyianke Biotech Description and Business Overview Table 177. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 178. Zhongyianke Biotech Product Table 179. Zhongyianke Biotech Recent Development Table 180. Bharat Biotech Corporation Information Table 181. Bharat Biotech Description and Business Overview Table 182. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 183. Bharat Biotech Product Table 184. Bharat Biotech Recent Development Table 185. Bavarian Nordic Corporation Information Table 186. Bavarian Nordic Description and Business Overview Table 187. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 188. Bavarian Nordic Product Table 189. Bavarian Nordic Recent Development Table 190. Sanofi-Pasteur Corporation Information Table 191. Sanofi-Pasteur Description and Business Overview Table 192. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 193. Sanofi-Pasteur Product Table 194. Sanofi-Pasteur Recent Development Table 195. Indian Immunologicals Corporation Information Table 196. Indian Immunologicals Description and Business Overview Table 197. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 198. Indian Immunologicals Product Table 199. Indian Immunologicals Recent Development Table 200. KANGH Corporation Information Table 201. KANGH Description and Business Overview Table 202. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 203. KANGH Product Table 204. KANGH Recent Development Table 205. Henan Grand Biopharma Corporation Information Table 206. Henan Grand Biopharma Description and Business Overview Table 207. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 208. Henan Grand Biopharma Product Table 209. Henan Grand Biopharma Recent Development Table 210. ZhongKe Biopharm Corporation Information Table 211. ZhongKe Biopharm Description and Business Overview Table 212. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 213. ZhongKe Biopharm Product Table 214. ZhongKe Biopharm Recent Development Table 215. Zhuoyi Biological Corporation Information Table 216. Zhuoyi Biological Description and Business Overview Table 217. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 218. Zhuoyi Biological Product Table 219. Zhuoyi Biological Recent Development Table 220. Human Vaccine Market Trends Table 221. Human Vaccine Market Drivers Table 222. Human Vaccine Market Challenges Table 223. Human Vaccine Market Restraints Table 224. Human Vaccine Customers List Table 225. Human Vaccine Distributors List Table 226. Research Programs/Design for This Report Table 227. Key Data Information from Secondary Sources Table 228. Key Data Information from Primary Sources List of Figures Figure 1. Human Vaccine Product Picture Figure 2. Global Human Vaccine Sales Market Share by Type in 2020 & 2027 Figure 3. Varicella Product Picture Figure 4. Influenza Product Picture Figure 5. Polio Product Picture Figure 6. Hepatitis A Product Picture Figure 7. Rabies Product Picture Figure 8. BCG Product Picture Figure 9. Hepatitis B Product Picture Figure 10. Pertussis, Diphtheria, Tetanus Product Picture Figure 11. Pneumococcal Product Picture Figure 12. Rota vaccine Product Picture Figure 13. Global Human Vaccine Sales Market Share by Application in 2020 & 2027 Figure 14. Adults Figure 15. Children Figure 16. Human Vaccine Report Years Considered Figure 17. Global Human Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Human Vaccine Market Size 2016-2027 (US$ Million) Figure 19. Global Human Vaccine Sales 2016-2027 (M Doses) Figure 20. Global Human Vaccine Market Size Market Share by Region: 2021 Versus 2027 Figure 21. Global Human Vaccine Sales Market Share by Region (2016-2021) Figure 22. Global Human Vaccine Sales Market Share by Region in 2020 Figure 23. Global Human Vaccine Revenue Market Share by Region (2016-2021) Figure 24. Global Human Vaccine Revenue Market Share by Region in 2020 Figure 25. Global Human Vaccine Sales Share by Manufacturer in 2020 Figure 26. The Top 10 and 5 Players Market Share by Human Vaccine Revenue in 2020 Figure 27. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 28. Global Human Vaccine Sales Market Share by Type (2016-2021) Figure 29. Global Human Vaccine Sales Market Share by Type in 2020 Figure 30. Global Human Vaccine Revenue Market Share by Type (2016-2021) Figure 31. Global Human Vaccine Revenue Market Share by Type in 2020 Figure 32. Global Human Vaccine Sales Market Share by Application (2016-2021) Figure 33. Global Human Vaccine Sales Market Share by Application in 2020 Figure 34. Global Human Vaccine Revenue Market Share by Application (2016-2021) Figure 35. Global Human Vaccine Revenue Market Share by Application in 2020 Figure 36. United States Human Vaccine Sales Growth Rate 2016-2027 (M Doses) Figure 37. United States Human Vaccine Revenue Growth Rate 2016-2027 (US$ Million) Figure 38. United States Human Vaccine Market Share in Global Market 2016-2027 Figure 39. United States 5 and 10 Largest Human Vaccine Players Market Share by Revenue in Human Vaccine in 2020 Figure 40. United States Human Vaccine Revenue Share by Type (2016-2021) Figure 41. United States Human Vaccine Revenue Growth Rate by Type in 2016 & 2020 Figure 42. United States Human Vaccine Revenue Share by Application (2016-2021) Figure 43. United States Human Vaccine Revenue Growth Rate by Application in 2016 & 2020 Figure 44. North America Human Vaccine Sales Growth Rate 2016-2021 (M Doses) Figure 45. North America Human Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. North America Human Vaccine Sales Market Share by Country in 2020 Figure 47. North America Human Vaccine Revenue Market Share by Country in 2020 Figure 48. U.S. Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 49. U.S. Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Canada Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 51. Canada Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. Europe Human Vaccine Sales Growth Rate 2016-2021 (M Doses) Figure 53. Europe Human Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 54. Europe Human Vaccine Sales Market Share by Country in 2020 Figure 55. Europe Human Vaccine Revenue Market Share by Country in 2020 Figure 56. Germany Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 57. Germany Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. France Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 59. France Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. U.K. Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 61. U.K. Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Italy Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 63. Italy Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Russia Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 65. Russia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Asia Pacific Human Vaccine Sales Growth Rate 2016-2021 (M Doses) Figure 67. Asia Pacific Human Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 68. Asia Pacific Human Vaccine Sales Market Share by Region in 2020 Figure 69. Asia Pacific Human Vaccine Revenue Market Share by Region in 2020 Figure 70. China Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 71. China Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Japan Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 73. Japan Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. South Korea Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 75. South Korea Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. India Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 77. India Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Australia Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 79. Australia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Taiwan Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 81. Taiwan Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Indonesia Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 83. Indonesia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Thailand Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 85. Thailand Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Malaysia Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 87. Malaysia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Philippines Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 89. Philippines Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Vietnam Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 91. Vietnam Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Latin America Human Vaccine Sales Growth Rate 2016-2021 (M Doses) Figure 93. Latin America Human Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 94. Latin America Human Vaccine Sales Market Share by Country in 2020 Figure 95. Latin America Human Vaccine Revenue Market Share by Country in 2020 Figure 96. Mexico Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 97. Mexico Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 98. Brazil Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 99. Brazil Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Argentina Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 101. Argentina Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Middle East and Africa Human Vaccine Sales Growth Rate 2016-2021 (M Doses) Figure 103. Middle East and Africa Human Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 104. Middle East and Africa Human Vaccine Sales Market Share by Country in 2020 Figure 105. Middle East and Africa Human Vaccine Revenue Market Share by Country in 2020 Figure 106. Turkey Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 107. Turkey Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 108. Saudi Arabia Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 109. Saudi Arabia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 110. U.A.E Human Vaccine Sales Growth Rate (2016-2021) (M Doses) Figure 111. U.A.E Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 112. Human Vaccine Value Chain Figure 113. Channels of Distribution Figure 114. Distributors Profiles Figure 115. Bottom-up and Top-down Approaches for This Report Figure 116. Data Triangulation Figure 117. Key Executives Interviewed

CNBG Changsheng Life Zhifei ChengDa Bio Kangtai SINOVAC BIOTECH Hissen Walvax Biotechnology GSK SANOFI Rong An NuoCheng Bio Hualan Bio Tiantan biological Changchun Baike Adimmune Zhongyianke Biotech Bharat Biotech Bavarian Nordic Sanofi-Pasteur Indian Immunologicals KANGH Henan Grand Biopharma ZhongKe Biopharm Zhuoyi Biological